NASDAQ: TVTX Travere Therapeutics, Inc. 8-K

Travere raises $525M via convertible notes, using $351M to repurchase existing 2029 debt

Filed May 11, 2026 · Period ending May 6, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TVTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 4:48 PM